Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 75

1.

Evaluation of the psychometric properties of the EORTC chemotherapy-induced peripheral neuropathy questionnaire (QLQ-CIPN20).

Kieffer JM, Postma TJ, van de Poll-Franse L, Mols F, Heimans JJ, Cavaletti G, Aaronson NK; CI-PeriNomS Group.

Qual Life Res. 2017 Jun 20. doi: 10.1007/s11136-017-1626-1. [Epub ahead of print]

PMID:
28634676
2.

Multiple Testing of Gene Sets from Gene Ontology: Possibilities and Pitfalls.

Meijer RJ, Goeman JJ.

Brief Bioinform. 2016 Sep;17(5):808-18. doi: 10.1093/bib/bbv091. Epub 2015 Oct 7.

PMID:
26446060
3.

Rasch-Transformed Total Neuropathy Score clinical version (RT-TNSc(©) ) in patients with chemotherapy-induced peripheral neuropathy.

Binda D, Cavaletti G, Cornblath DR, Merkies IS; CI-PeriNomS study group.

J Peripher Nerv Syst. 2015 Sep;20(3):328-32. doi: 10.1111/jns.12140.

PMID:
26306547
4.

A region-based multiple testing method for hypotheses ordered in space or time.

Meijer RJ, Krebs TJ, Goeman JJ.

Stat Appl Genet Mol Biol. 2015 Feb;14(1):1-19. doi: 10.1515/sagmb-2013-0075.

PMID:
25525753
5.

A multiple testing method for hypotheses structured in a directed acyclic graph.

Meijer RJ, Goeman JJ.

Biom J. 2015 Jan;57(1):123-43. doi: 10.1002/bimj.201300253. Epub 2014 Nov 13.

PMID:
25394320
6.

Correspondence between neurophysiological and clinical measurements of chemotherapy-induced peripheral neuropathy: secondary analysis of data from the CI-PeriNomS study.

Griffith KA, Dorsey SG, Renn CL, Zhu S, Johantgen ME, Cornblath DR, Argyriou AA, Cavaletti G, Merkies IS, Alberti P, Postma TJ, Rossi E, Frigeni B, Bruna J, Velasco R, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galie E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey DJ, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG; CI-PeriNomS Group.

J Peripher Nerv Syst. 2014 Jun;19(2):127-35. doi: 10.1111/jns5.12064.

7.

Time-frequency methods for structural health monitoring.

Pyayt AL, Kozionov AP, Mokhov II, Lang B, Meijer RJ, Krzhizhanovskaya VV, Sloot PM.

Sensors (Basel). 2014 Mar 12;14(3):5147-73. doi: 10.3390/s140305147.

8.

Physician-assessed and patient-reported outcome measures in chemotherapy-induced sensory peripheral neurotoxicity: two sides of the same coin.

Alberti P, Rossi E, Cornblath DR, Merkies IS, Postma TJ, Frigeni B, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG, Cavaletti G; CI-PeriNomS Group.

Ann Oncol. 2014 Jan;25(1):257-64. doi: 10.1093/annonc/mdt409. Epub 2013 Nov 19.

9.

Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS).

Binda D, Vanhoutte EK, Cavaletti G, Cornblath DR, Postma TJ, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Rossi E, Valsecchi MG, Faber CG, Merkies IS; CI-PeriNomS study group, Galimberti S, Lanzani F, Mattavelli L, Piatti ML, Bidoli P, Cazzaniga M, Cortinovis D, Lucchetta M, Campagnolo M, Bakkers M, Brouwer B, Boogerd W, Grant R, Reni L, Piras B, Pessino A, Padua L, Granata G, Leandri M, Ghignotti I, Plasmati R, Pastorelli F, Heimans JJ, Eurelings M, Meijer RJ, Grisold W, Lindeck Pozza E, Mazzeo A, Toscano A, Russo M, Tomasello C, Altavilla G, Penas Prado M, Dominguez Gonzalez C, Dorsey SG.

Eur J Cancer. 2013 Sep;49(13):2910-8. doi: 10.1016/j.ejca.2013.04.004. Epub 2013 May 10.

PMID:
23668917
10.

Efficient approximate k-fold and leave-one-out cross-validation for ridge regression.

Meijer RJ, Goeman JJ.

Biom J. 2013 Mar;55(2):141-55. doi: 10.1002/bimj.201200088. Epub 2013 Jan 24.

PMID:
23348970
11.

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings.

Cavaletti G, Cornblath DR, Merkies IS, Postma TJ, Rossi E, Frigeni B, Alberti P, Bruna J, Velasco R, Argyriou AA, Kalofonos HP, Psimaras D, Ricard D, Pace A, Galiè E, Briani C, Dalla Torre C, Faber CG, Lalisang RI, Boogerd W, Brandsma D, Koeppen S, Hense J, Storey D, Kerrigan S, Schenone A, Fabbri S, Valsecchi MG; CI-PeriNomS Group.

Ann Oncol. 2013 Feb;24(2):454-62. doi: 10.1093/annonc/mds329. Epub 2012 Aug 21.

12.

In vivo hemostatic efficacy of polyurethane foam compared to collagen and gelatin.

Broekema FI, van Oeveren W, Selten MH, Meijer RJ, de Wolf JT, Bos RR.

Clin Oral Investig. 2013 May;17(4):1273-8. doi: 10.1007/s00784-012-0809-y. Epub 2012 Aug 2.

PMID:
22855267
13.

Early administration of aspirin in patients treated with alteplase for acute ischaemic stroke: a randomised controlled trial.

Zinkstok SM, Roos YB; ARTIS investigators.

Lancet. 2012 Aug 25;380(9843):731-7. doi: 10.1016/S0140-6736(12)60949-0. Epub 2012 Jun 28.

PMID:
22748820
14.

Modifying the Medical Research Council grading system through Rasch analyses.

Vanhoutte EK, Faber CG, van Nes SI, Jacobs BC, van Doorn PA, van Koningsveld R, Cornblath DR, van der Kooi AJ, Cats EA, van den Berg LH, Notermans NC, van der Pol WL, Hermans MC, van der Beek NA, Gorson KC, Eurelings M, Engelsman J, Boot H, Meijer RJ, Lauria G, Tennant A, Merkies IS; PeriNomS Study Group.

Brain. 2012 May;135(Pt 5):1639-49. doi: 10.1093/brain/awr318. Epub 2011 Dec 20.

15.

In-field radon measurement in water: a novel approach.

Talha SA, de Meijer RJ, Lindsay R, Newman RT, Maleka PP, Hlatshwayo IN.

J Environ Radioact. 2010 Dec;101(12):1024-31. doi: 10.1016/j.jenvrad.2010.07.005. Epub 2010 Sep 15.

PMID:
20832920
16.

No evidence for antineutrinos significantly influencing exponential β+ decay.

de Meijer RJ, Blaauw M, Smit FD.

Appl Radiat Isot. 2011 Feb;69(2):320-6. doi: 10.1016/j.apradiso.2010.08.002. Epub 2010 Aug 7.

PMID:
20727777
17.

PATCH: platelet transfusion in cerebral haemorrhage: study protocol for a multicentre, randomised, controlled trial.

de Gans K, de Haan RJ, Majoie CB, Koopman MM, Brand A, Dijkgraaf MG, Vermeulen M, Roos YB; PATCH Investigators.

BMC Neurol. 2010 Mar 18;10:19. doi: 10.1186/1471-2377-10-19.

18.

C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death.

den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ, Dippel DW; PAIS investigators.

J Neurol. 2009 Dec;256(12):2003-8. doi: 10.1007/s00415-009-5228-x.

19.

The Paracetamol (Acetaminophen) In Stroke (PAIS) trial: a multicentre, randomised, placebo-controlled, phase III trial.

den Hertog HM, van der Worp HB, van Gemert HM, Algra A, Kappelle LJ, van Gijn J, Koudstaal PJ, Dippel DW; PAIS Investigators.

Lancet Neurol. 2009 May;8(5):434-40. doi: 10.1016/S1474-4422(09)70051-1. Epub 2009 Mar 16.

PMID:
19297248
20.

Gamma-ray spectrometry of radon in water and the role of radon to representatively sample aquifers.

Talha SA, Lindsay R, Newman RT, de Meijer RJ, Maleka PP, Hlatshwayo IN, Mlwilo NA, Mohanty AK.

Appl Radiat Isot. 2008 Nov;66(11):1623-6. doi: 10.1016/j.apradiso.2007.12.016. Epub 2008 Apr 18.

PMID:
18515121

Supplemental Content

Loading ...
Support Center